Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models

Current Opinion in Genetics and Development

Volumn 12, Issue 3, 2002, Pages 349-361

  Durbeej, Madeleine ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GLYCOPROTEIN; CALCIUM BINDING PROTEIN; CARRIER PROTEIN; CAV3 PROTEIN, MOUSE; CAVEOLIN; CAVEOLIN 3; CYTOSKELETON PROTEIN; DAG1 PROTEIN, HUMAN; DYSTROBREVIN; DYSTROGLYCAN; DYSTROPHIN ASSOCIATED PROTEIN; INTEGRIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; NEUROPEPTIDE; SSPN PROTEIN, HUMAN; SSPN PROTEIN, MOUSE; SYNTROPHIN ALPHA1; TUMOR PROTEIN;

BIOAVAILABILITY; CARDIOMYOPATHY; CYTOSKELETON; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE MUTATION; GENETIC ENGINEERING; HAMSTER; HUMAN; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY MECHANISM; REVIEW; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; TRANSGENIC MOUSE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALIA; CANIS FAMILIARIS; CRICETINAE; FELIS CATUS;

ANIMALS; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CAVEOLIN 3; CAVEOLINS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; DYSTROPHIN; DYSTROPHIN-ASSOCIATED PROTEINS; GLYCOPROTEINS; HUMANS; INTEGRINS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; NEOPLASM PROTEINS; NEUROPEPTIDES;

EID: 0036591684     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(02)00309-X     Document Type: Review

References (133)

1. Molecular basis of three muscular dystrophies: Disruption of the cytoskeleton-extracellular matrix linkage
2. Muscular dystrophies and the dystrophin-glycoprotein complex
3. The sarcoglycan complex in limb-girdle muscular dystrophy
4. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms
5. The molecular basis of muscular dystrophies
6. Dystrophin: The protein product of the Duchenne muscular dystrophy locus
7. Association of dystrophin and an integral membrane glycoprotein
8. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
9. Glycoprotein complex anchoring dystrophin to sarcolemma
10. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
11. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
12. Two isoforms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution
13. Identification of alpha-syntrophin binding to the syntrophin triplet, dystrophin and utrophin
14. Beta-sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12
15. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
16. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy
17. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene
18. Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy
19. Sarcospan, the 25 kDa transmembrane component of the dystrophin-glycoprotein complex
20. γ1- and γ2-syntrophins, two novel dystrophin binding proteins localized in neuronal cells
21. Role for the α-dystrobrevin in the pathogenesis of dystrophin dependent muscular dystrophies
22. Membrane organization of the dystrophin-glycoprotein complex
23. A role for dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
24. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain to dy locus
25. A role for dystrophin associated glycoproteins and utrophin in agrin-induced AChR clustering
26. Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor
27. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins
28. The small leucine-rich repeat proteoglycan biglycan binds to α-dystroglycan and is upregulated in dystrophic muscle
29. A stochiometric complex of neurexins and dystroglycan in brain
30. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions
31. Dystrophin protects the sarcolemma from stresses developed during muscle contraction
32. Primary adhalinopathy: A common cause of autosomal recessive muscular dystrophy of variable severity
33. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain
34. SH3 domain mediated interaction of dystroglycan and Grb2
35. Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein
36. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives
37. Differential association of syntrophin pairs with the dystrophin complex
38. Interaction with nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PZD domains
39. Specific interactions between the syntrophin PDZ domain and the voltage-gated sodium channels
40. Interaction of brain and muscle sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins
41. Interactions between β2-syntrophin and family of microtubule-associated serine/threonine kinases
42. The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin
43. Dystrobrevin and dystrophin: An interaction through coiled-coil motifs
44. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathies
45. Dystrophins in vertebrates and invertebrates
46. Conservation of components of the dystrophin complex in Drosophila
47. Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes
48. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
49. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice
50. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) in the mouse
51. The mdx diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
52. The capacity of mdx mouse diaphragm muscle to do oscillatory work
53. MyoD is required for myogenic stem cell function in adult skeletal muscle
54. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF
55. Utrophin-dystrophin-deficient mice as a model for Duchenne Muscular Dystrophy
56. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy
57. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice
58. Progressive muscular dystrophy in α-sarcoglycan deficient mice
59. An alternative dystrophin transcript specific to peripheral nerve
60. Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: Expression during mouse embryogenesis and in cultured cell lines
61. A novel dystrophin isoforms is required for normal retinal electrophysiology
62. Dp140: A novel 140 kDa CNS transcript from the dystrophin locus
63. Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis
64. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: Differential activity of the Dp71 promoter during development
65. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations
66. Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice
67. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy
68. α1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration
69. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
70. Aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte endfeet in α1-syntrophin knockout mice
71. Immunocytochemical studies of aquaporin-4 in the skeletal muscle
72. Skeletal muscle function and water permeability in aquaporin-4 deficient mice
73. Targeted disruption of the nitric oxide synthase gene
74. Mdx muscle pathology is independent of nNOS perturbation
75. Functional muscle ischemia in neuronal nitric oxide synthase deficient skeletal muscle of children with Duchenne muscular dystrophy
76. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
77. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells: Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated proteins
78. Caveolin-3 is not an integral component of the dystrophin-glycoprotein complex
79. Caveolin-3 deficiency causes muscle degeneration in mice
80. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities
81. Biochemical characterization of the epithelial dystroglycan complex
82. Non-muscle α-dystroglycan is involved in epithelial development
83. Distribution of dystroglycan in normal adult mouse tissues
84. A role for dystroglycan in basement membrane assembly
85. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
86. Chimeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted monaural synapses
87. Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse
88. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1
89. Deficiency of α-dystroglycan in muscle-eye-brain disease
90. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy
91. The Peter Emil Becker Award lecture: The saga of congenital muscular dystrophy
92. Dystrophia muscularis: A hereditary primary myopathy in the house mouse
93. Defective muscle basement membrane and lack of M-laminin in the dy/dy mouse
94. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene
95. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lam2 gene: A new model of merosin (laminin 2)-deficient congenital muscular dystrophy
96. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models
97. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy
98. Integrins: Versatility, modulation, and signaling in cell adhesion
99. The α7β1 integrin in muscle development and disease
100. Absence of integrin α7 causes a novel form of muscular dystrophy
101. Altered expression of the α7β1 integrin in human and murine muscular dystrophies
102. Secondary reduction of alpha7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
103. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice
104. Dystrophic muscle in mice chimeric for expression of α5 integrin
105. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex
106. Concomitant deficiency of β- and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients: Immunohistochemical analysis and clinical aspects
107. Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan domains
108. Sarcospan-deficient mice maintain normal muscle function
109. ε-sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex
110. Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex
111. γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
112. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
113. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan deficient mice
114. Sarcoglycan isoforms in skeletal muscle
115. Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
116. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex
117. Ecto-ATPase activity of α-sarcoglycan (adhalin)
118. Muscle degeneration without mechanical injury in sarcoglycan deficiency
119. Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan deficient mice
120. Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer
121. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy
122. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IκBα/nuclear factor κB pathway perturbation in mice
123. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B
124. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene
125. Mutations in the fukutin-related protein identify limb-girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C
126. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen typeVI
127. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease
128. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome
129. Collagen VI deficiency induces early onset myopathy in the mouse: An animal model for Bethlem myopathy
130. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
131. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture
132. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
133. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy